ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 278631 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 278631; 2) Community: the network communities that were significantly associated with the response to NSC 278631; 3) Molecule: the relationships between components within communities and NSC 278631; 4) MDR: the compounds that were significantly associated with the NSC 278631.

NSC Compound Enrichment Correlation
NSC 688997 Null 0.0238174255956147 0.11578212
NSC 693867 Null 0.0238174255956147 0.07769797
NSC 709518 Null 0.0238174255956147 0.38669754
NSC 716122 Null 0.0238174255956147 0.18734172
NSC 724781 (1S,4R,5R,8R,12R,13S)-9-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl -10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10.3.1. 04,13.08,13]hexadec-9-en-9-yl]methoxy}-2-butenyl)oxy]methyl} -1,5-dimethyl-10 0.0238174255956147 0.13125688
NSC 727086 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-3a-pyrrolidino-5-androsten-17a-yl acetate 0.0238174255956147 0.22529123
NSC 730944 3-bromo-4-(2-(4-methoxyphenyl)ethynyl)furan-2(5H)-one 0.0238174255956147 -0.030255736
NSC 740345 3-3'-(1H-pyrazole-3,5-diyl)bis(1-methyl-1H-indole) 0.0238174255956147 -0.088219782
NSC 748643 Mitaplatin 0.0238174255956147 0.24835321
NSC 7521 [(6-Deoxy-.alpha.-L-mannopyranosyl)oxy]-14-hydroxybufa-4,20,22-trienolide 0.0238174255956147 0.23840202
Total:92  Current:40    [First] [Prev] [Next] [Last]